Provided by Tiger Fintech (Singapore) Pte. Ltd.

BioLine Rx

4.40
-0.0832-1.86%
Volume:48.80K
Turnover:214.25K
Market Cap:16.38M
PE:-3.20
High:4.55
Open:4.55
Low:4.25
Close:4.49
Loading ...

BioLine RX Price Target Maintained With a $26.00/Share by HC Wainwright & Co.

Dow Jones
·
17 Jun

BioLine RX Raised to Buy From Hold by Jones Trading

Dow Jones
·
30 May

BioLine RX Ltd : Jonestrading Raises to Buy From Hold

THOMSON REUTERS
·
30 May

Bioline Says Pilot Study of Potential Pancreatic Cancer Drug Combo Shows Improved Overall Response Rate; Shares Soar Pre-Bell

MT Newswires Live
·
30 May

Top Premarket Gainers

MT Newswires Live
·
30 May

JonesTrading Reaffirms Their Hold Rating on Bioline RX Ltd Sponsored ADR (BLRX)

TIPRANKS
·
28 May

BioLine RX Price Target Maintained With a $26.00/Share by HC Wainwright & Co.

Dow Jones
·
28 May

BioLine Rx Q1 2025 EPS $0.00 May Not Be Comparable To $(1.20) Estimate, Sales $255.00K Vs. $6.86M YoY

Benzinga
·
27 May

Press Release: BioLineRx Reports First Quarter 2025 Financial Results and Provides Corporate Update

Dow Jones
·
27 May

BioLine RX Ltd expected to post a loss of 93 cents a share - Earnings Preview

Reuters
·
23 May

BLRX: 2024 Financial Results

Zacks Small Cap Research
·
03 Apr

BioLine Rx Ltd (BLRX) Q4 2024 Earnings Call Highlights: Strategic Licensing and Market ...

GuruFocus.com
·
03 Apr

BioLine RX Cut to Hold From Buy by Jones Trading

Dow Jones
·
02 Apr

BioLineRx downgraded to Hold from Buy at JonesResearch

TIPRANKS
·
02 Apr

JonesTrading downgrades Bioline RX Ltd Sponsored ADR (BLRX) to a Hold

TIPRANKS
·
02 Apr

BioLine RX Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
01 Apr

BioLine RX Ltd : H.c. Wainwright Adjusts Target Price to $26 From $9 to Reflect 1-for-40 Reverse Stock Split

THOMSON REUTERS
·
31 Mar

Options Volatility and Implied Earnings Moves Today, March 31, 2025

TIPRANKS
·
31 Mar

Options Volatility and Implied Earnings Moves This Week, March 31 – April 03, 2025

TIPRANKS
·
31 Mar

Press Release: BioLineRx Reports 2024 Financial Results and Provides Corporate Update

Dow Jones
·
31 Mar